Historic outbreaks of the Ebola virus are typically isolated and usually affect a few hundred people at a time. However, with innovative vaccines and antibody treatments available, recent Ebola outbreaks have been limited and less fatal.
However, the current Sudan Ebolovius (SUDV) outbreak in the Republic of Uganda does not have access to U.S. FDA-approved vaccines or treatments.
And recent data from the Uganda Ministry of Health posted on Twitter indicates the SUDV case fatality rate exceeds 40%.
Read More
